GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Daxor Corp (FRA:DX5) » Definitions » Scaled Net Operating Assets

Daxor (FRA:DX5) Scaled Net Operating Assets : 1.14 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Daxor Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Daxor's operating assets for the quarter that ended in Dec. 2023 was €31.98 Mil. Daxor's operating liabilities for the quarter that ended in Dec. 2023 was €0.10 Mil. Daxor's Total Assets for the quarter that ended in Jun. 2023 was €28.02 Mil. Therefore, Daxor's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was 1.14.


Daxor Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Daxor's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(31.975-0.095)/28.566
=1.12

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Balance Sheet Cash And Cash Equivalents
=31.975 - 0
=31.975

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.788 - 0.693 - 0
=0.095

Daxor's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2023 )
=(Operating Assets (Q: Dec. 2023 )-Operating Liabilities (Q: Dec. 2023 ))/Total Assets (Q: Jun. 2023 )
=(31.975-0.095)/28.021
=1.14

where

Operating Assets(Q: Dec. 2023 )
=Total Assets - Balance Sheet Cash And Cash Equivalents
=31.975 - 0
=31.975

Operating Liabilities(Q: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.788 - 0.693 - 0
=0.095

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Daxor Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Daxor's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Daxor (FRA:DX5) Business Description

Traded in Other Exchanges
Address
109 Meco Lane, Oak Ridge, TN, USA, 37830
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.